Explore more publications!

Today in Medicine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.

Press releases published on October 25, 2025

The Genome Frontier: How KFSHRC is Redefining the Future of Precision Medicine
VIBE at Global Health Exhibition 2025 Celebrates Wellness, Longevity, and the Future of Healthy Living
Asad’s Hot Chicken Announces 'THE MAC DROP' — A New Mac & Cheese Menu Launch
Nexus Teen Academy Blends Mental Health Recovery With Education for Arizona Teens
Inside KFSHRC’s AI Revolution: Building Trust, Efficiency, and the Future of Healthcare
#1 Texas Local Medicare Agent Doubles Client Base Amid 2026 Medicare Part D Disruptions
Proactive MD Expands Integrated Care Capabilities with Recent Acquisitions
Beyond Gravity: How KFSHRC is Shaping the Future of Space Medicine
Inside the New KFSHRC Biobank: Building the Foundation for Healthier, Data Driven Future
KFSHRC Enhances Brain Tumor Surgery Precision with Fluorescence-Guided Technology
Filling the Care Gap: How KFSHRC’s New Program Redefines Palliative Care for Young Lives
Breaking Barriers of Compatibility: How KFSHRC’s Paired Kidney Transplants Are Transforming Lives
Restoring Wholeness: How KFSHRC Jeddah’s Robotic Breast Surgery Is Changing the Experience of Healing
Where to Buy Kratom Online: Kratom Bird Stands Out Among the Best Kratom Brands in Europe
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing…
Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
Quell Therapeutics to Unveil Promising Data for QEL-005, a Novel CAR-Treg Cell Therapy for Complex Autoimmune Diseases, at ACR Convergence 2025
Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions